Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Open in API
Filings indexed 428 across all filing types
Latest filing 2025-05-24 Board/Management Inform…
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Appointment
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to the National Stock Exchange of India regarding the outcome of a Board Meeting held on 24th May 2025. The key content is the appointment of a new Chief Financial Officer, Mr. Dewansh Ajay Vasani, who is also an Executive Director. The document includes detailed information about the appointee as required under SEBI regulations. There are no financial statements, earnings data, or detailed management discussion of financial results. The document is primarily about a change in senior management, specifically the appointment of a key managerial personnel. Therefore, this fits the category of Board/Management Information (MANG). The document length is 3444 characters, which is consistent with a typical management change announcement rather than a full report or earnings release.
2025-05-24 English
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is a formal announcement addressed to the National Stock Exchange of India regarding the outcome of a Board Meeting held on 24th May 2025. The key content is the appointment of Mr. Dewansh Ajay Vasani as Chief Financial Officer and Executive Director. The document includes details required under Regulation 30 of SEBI Listing Regulations about the appointment of a key managerial personnel. There are no financial statements, earnings data, or detailed reports. The document is primarily about a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3444 characters, which is consistent with an announcement rather than a full report.
2025-05-24 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-05-19 English
Change in Management
Board/Management Information Classification · 95% confidence The document is an official communication addressed to the National Stock Exchange of India, referencing Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the appointment and re-appointment of two independent directors, including details about their terms and profiles. The document includes disclosures required under Regulation 30 and mentions a postal ballot and scrutinizer report. There are no financial statements or detailed financial performance data. The content focuses on changes in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length is about 4800 characters, which is consistent with a detailed announcement rather than a full report or brief notice.
2025-04-26 English
Amendment to AOA/MOA
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to the National Stock Exchange of India regarding a special resolution passed through a postal ballot. The resolution pertains to the alteration of the Main Objects clause of the company's Memorandum of Association (MOA). The document includes a summary of the amendments and references compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, specifically Regulation 30 which deals with disclosure of material events. The content is an announcement of a corporate governance event (alteration of MOA) rather than a full report or financial statement. It is not a full Annual Report, Interim Report, or any financial statement. It is also not a voting result declaration per se, but an intimation of a corporate action following a shareholder vote. The document is relatively short (3361 characters) and serves as a regulatory announcement of a corporate governance change. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-04-26 English
Shareholders meeting
Regulatory Filings
2025-04-25 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.